Boeing and Rocket Lab: A Comparison of Aerospace Investment Opportunities for 2026

Boeing holds a prominent position among defense stocks and commercial aviation, producing aircraft like the 737 Max and advanced military rotorcraft. In 2025, the company generated nearly $89.5 billion in revenue, marking a 34.5% increase from the previous year. It also reported a net income of about $2.2 billion, a rebound from a net loss of roughly $11.8 billion in FY 2024, indicating progress in stabilizing its financial performance. However, with a debt-to-equity ratio of nearly 10.0x, Boeing relies heavily on borrowing, and its current ratio stands at approximately 1.2x, highlighting its ability to meet short-term liabilities. In FY 2025, Boeing also faced negative free cash flow of about $1.9 billion due to substantial operating costs.

Rocket Lab, focusing on end-to-end space solutions, recorded approximately $601.8 million in revenue for FY 2025, which is a 38% increase from FY 2024. Nonetheless, it reported a net loss of nearly $198.2 million, slightly worsening from a loss of around $190.2 million the prior year. Despite improvements in net margin, Rocket Lab remains unprofitable as it invests heavily in its Neutron program. Its balance sheet, however, is conservative, with a current ratio of nearly 4.1x and a debt-to-equity ratio of approximately 0.1x. Free cash flow was negative $321.8 million, largely due to the costs associated with developing new launch vehicles.

Boeing confronts numerous operational challenges, including delays in the delivery of the 777X and 737 aircraft due to restrictions from the FAA. Additionally, it faces potential losses on fixed-price defense contracts and risks related to geopolitical tensions with China, which accounted for about 46% of its FY 2025 revenue. In its restructuring efforts, integrating Spirit AeroSystems also poses complexities.

Rocket Lab's risks are mainly linked to its rapid growth and high capital expenditures for the Neutron project. Any failures in launching its Electron rocket could disrupt revenue and escalate insurance costs. The company competes with established entities like Lockheed Martin (LMT +0.77%) and Northrop Grumman (NOC +0.73%). Its future profitability relies on effective integration of acquisitions and ongoing government funding for space initiatives.

In terms of valuation, Boeing appears less expensive on a sales basis, whereas Rocket Lab’s valuation reflects investor expectations for growth despite its current lack of profits. For example, Boeing has a forward P/E ratio of 52.1x compared to Rocket Lab’s 1,000x, while Boeing’s price-to-sales ratio stands at 1.7x against Rocket Lab’s 47.8x.

Despite its challenges, Rocket Lab is on a growth trajectory that could attract investors interested in the commercialization of space. The company secured more launch contracts in one quarter than during the entire previous year, and the Neutron rocket program is expected to enhance its market reach. Boeing, too, has shown promising recovery signs, with a rise in commercial deliveries and positive free cash flow, alongside an important restoration of self-certification authority from the FAA.

In conclusion, while both companies have unique strengths and challenges, Rocket Lab currently presents an appealing option for investors willing to embrace volatility in pursuit of high growth in the aerospace sector.